Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth?
Economy

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth?

Last updated: April 18, 2025 3:14 pm
Share
Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth?
SHARE

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has been making waves in the pharmaceutical industry, particularly in the field of central nervous system (CNS) diseases. With a focus on developing and selling medications for conditions such as epilepsy, migraine, ADHD, and Parkinson’s disease, Supernus Pharmaceuticals has established itself as a key player in the market.

In the third quarter of 2024, Supernus Pharmaceuticals reported impressive financial results, with overall revenues increasing by 14% to $175.7 million. The company’s net product sales saw a significant boost to $170.3 million, driven by the success of key products like Qelbree and Gocovri. Operating earnings also saw a notable increase to $40.9 million, with net earnings rising to $38.5 million, or $0.69 per diluted share.

One of the standout performers for Supernus Pharmaceuticals in Q3 2024 was the non-stimulant ADHD medication Qelbree, which saw a 68% increase in sales to $62.4 million. Looking ahead, the company is strategically positioning itself for future growth in the CNS market by adding promising therapeutic candidates to its pipeline, such as SPN-830, SPN-817, and SPN-820.

Currently, Supernus Pharmaceuticals ranks 8th on the list of best pharma stocks to buy for long-term growth. While the potential of SUPN as an investment is recognized, there is a strong belief that AI stocks hold even greater promise for delivering higher returns in a shorter timeframe. As such, investors are encouraged to explore the opportunities presented by AI stocks that have shown significant growth potential.

In conclusion, Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) continues to be a key player in the pharmaceutical industry, particularly in the CNS market. With a focus on developing innovative medications for a range of neurological conditions, the company’s strong financial performance and strategic pipeline expansion position it well for future growth and success in the market.

See also  New Research Provides Clues About Cause Of Long Covid

For more insights on top-performing stocks and investment opportunities, be sure to check out our latest reports on the best AI stocks to buy now and the top stocks recommended by billionaires. Disclosure: None.

TAGGED:BuyGrowthLongPharmaPharmaceuticalsStockSupernusSUPNTerm
Share This Article
Twitter Email Copy Link Print
Previous Article How THC, the Psychoactive Compound in Weed, Gets You High How THC, the Psychoactive Compound in Weed, Gets You High
Next Article Summer House’s Lexi Wood Talks Jesse Solomon Split After Season 9 Summer House’s Lexi Wood Talks Jesse Solomon Split After Season 9
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Trump NYC rally crowd pissed about lack of toilets

Trump Supporters Forced to Find Creative Solutions for Restroom Needs at MSG Rally Attendees of…

October 27, 2024

76 Easy Science Experiments Using Materials You Already Have

Learn more: Liquid Layers Science Project 11. Bend water with static electricity This simple demonstration…

December 16, 2024

R. Kelly’s Fiancée Says She’s Not A Victim or Brainwashed Despite Family’s Claims

R. Kelly's Fiancée I'm Not His Sex Slave My Parents Are Lying!!! Published June 22,…

June 22, 2025

Trans rights and legal wrongs

The issue of rights for transgender individuals has long been a contentious one, with legislation…

April 25, 2025

Study Finds Meditation Offers Genuine Pain Relief : ScienceAlert

Using Mindfulness Meditation for Pain Relief: A Closer Look If you're in a lot of…

September 29, 2024

You Might Also Like

What is a merchant bank?
Economy

What is a merchant bank?

October 30, 2025
Nanotyrannus: Dinosaur skeleton settles long debate over ‘tiny T. rex’ fossils
Tech and Science

Nanotyrannus: Dinosaur skeleton settles long debate over ‘tiny T. rex’ fossils

October 30, 2025
Fed Cuts Rates by a Quarter Point, as Expected
Economy

Fed Cuts Rates by a Quarter Point, as Expected

October 30, 2025
Fed’s Standing Repo Facility hits record high as policy meeting outcome looms
Economy

Fed’s Standing Repo Facility hits record high as policy meeting outcome looms

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?